DOCSLIB.ORG

Supplementary Data: Table S1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

SUPPLEMENTARY DATA: TABLE S1 acetal 3_hydroxybenzaldehyde 2_methylpropene 11_diethoxyethane 4_formylpyridine 3_chloroprop_1_ene dimethoxymethane 4_hydroxybenzaldehyde 3_methylbut_1_ene 4_methylbenzaldehyde alpha_methylstyrene acid acetaldehyde but_1_ene 3_methylbutanoic_acid benzaldehyde buta_13_diene acetic_acid butyraldehyde chloroethylene butanoic_acid e_but_2_enal cyclohepta_135_triene hexanoic_acid e_hex_2_enal cyclohexene pentanoic_acid e_oct_2_enal cyclopentene propanoic_acid formaldehyde e_12_dichloroethene heptanal e_but_2_enal alcohol hexanal e_hept_2_ene 111_trifluoropropan_2_ol isobutyraldehyde e_hex_2_enal 12_ethanediol nonanal e_oct_2_enal 222_trifluoroethanol octanal ethene 2_butoxyethanol pentanal hept_1_ene 2_ethoxyethanol propionaldehyde hex_1_ene 2_methoxyethanol hexa_15_diene 2_methylbutan_1_ol alkane non_1_ene 2_methylbutan_2_ol 224_trimethylpentane oct_1_ene 2_methylpentan_2_ol 225_trimethylhexane pent_1_ene 2_methylpentan_3_ol 22_dimethylbutane penta_14_diene 2_methylpropan_1_ol 22_dimethylpentane prop_2_en_1_ol 2_methylpropan_2_ol 22_dimethylpropane propene 2_phenylethanol 234_trimethylpentane styrene 2_propoxyethanol 23_dimethylbutane z_12_dichloroethene 3_methylbutan_1_ol 23_dimethylpentane z_pent_2_ene 3_phenylpropanol 24_dimethylpentane trichloroethene 4_methylpentan_2_ol 2_methylbutane tetrachloroethene benzyl_alcohol 2_methylhexane butan_1_ol 2_methylpentane alkyne butan_2_ol 2_methylpropane but_1_yne cycloheptanol 33_dimethylpentane hept_1_yne cyclohexanol 3_methylheptane hex_1_yne cyclopentanol 3_methylhexane oct_1_yne decan_1_ol 3_methylpentane pent_1_yne ethanol ethane propyne heptan_1_ol methane hexan_1_ol n_butane amine hexan_3_ol n_decane 14_dimethyl_piperazine methanol n_heptane 1_naphthylamine nonan_1_ol n_hexane 26_dimethylaniline octan_1_ol n_nonane 2_chloroaniline pentan_1_ol n_octane 2_methoxyaniline pentan_2_ol n_pentane 2_methoxyethanamine pentan_3_ol propane 2_naphthylamine prop_2_en_1_ol 2_nitroaniline propan_1_ol alkene 3_chloroaniline propan_2_ol 1_methylcyclohexene 3_methoxyaniline triacetyl_glycerol 23_dimethylbuta_13_diene 3_nitroaniline 2_methylbut_2_ene 4_chloroaniline aldehyde 2_methylbuta_13_diene 4_methoxyaniline 3_formylpyridine 2_methylpent_1_ene 4_nitroaniline 1 aniline 24_dimethylphenol 4_chlorophenol azetidine 24_dimethylpyridine 4_cyanophenol cyclohexylamine 25_dimethylphenol 4_cyanopyridine diethylamine 25_dimethylpyridine 4_ethylphenol diisopropylamine 26_dimethylaniline 4_ethylpyridine dimethylamine 26_dimethylnaphthalene 4_ethyltoluene di_n_butylamine 26_dimethylphenol 4_fluorophenol di_n_propylamine 26_dimethylpyridine 4_formylpyridine ethylamine 2_chloroaniline 4_hydroxybenzaldehyde methylamine 2_chlorophenol 4_isopropyltoluene morpholine 2_chloropyridine 4_methoxyacetophenone n_butylamine 2_chlorotoluene 4_methoxyaniline n_heptylamine 2_ethylpyrazine 4_methyl_1h_imidazole n_hexylamine 2_ethylpyridine 4_methylacetophenone n_methylaniline 2_ethyltoluene 4_methylbenzaldehyde n_methylmorpholine 2_fluorophenol 4_methylpyridine n_methyl_n__222_trifluoroet 2_iodophenol 4_nitroaniline hyl__aniline 2_isobutylpyrazine 4_nitrophenol n_methylpiperazine 2_methoxyaniline 4_n_propylphenol n_methylpiperidine 2_methoxyphenol 4_tert_butylphenol nn_dimethylaniline 2_methylpyrazine acenaphthene n_octylamine 2_methylpyridine acetophenone n_pentylamine 2_methylthiophene alpha_methylstyrene n_propylamine 2_naphthol aniline o_toluidine 2_naphthylamine anisole piperazine 2_nitroaniline anthracene piperidine 2_nitrophenol benzaldehyde p_toluidine 2_nitrotoluene benzamide pyrrolidine 2_phenylethanol benzene triethylamine 34_dimethylphenol benzonitrile trimethylamine 34_dimethylpyridine benzotrifluoride 35_dimethylphenol benzyl_alcohol aromatic 35_dimethylpyridine benzyl_bromide 1234_tetrachlorobenzene 3_acetylpyridine benzyl_chloride 1235_tetrachlorobenzene 3_chloroaniline biphenyl 123_trichlorobenzene 3_chlorophenol bromobenzene 123_trimethylbenzene 3_chloropyridine chlorobenzene 1245_tetrachlorobenzene 3_cyanophenol diethoxymethoxybenzene 124_trichlorobenzene 3_cyanopyridine ethylbenzene 124_trimethylbenzene 3_ethylphenol ethyl_benzoate 12_dichlorobenzene 3_ethylpyridine ethyl_phenyl_ether 135_trichlorobenzene 3_formylpyridine fluorene 135_trimethylbenzene 3_hydroxybenzaldehyde fluorobenzene 13_dichlorobenzene 3_methoxyaniline imidazole 13_dimethylnaphthalene 3_methoxyphenol indane 14_dichlorobenzene 3_methyl_1h_indole iodobenzene 14_dimethylnaphthalene 3_methylpyridine isobutylbenzene 1_ethylnaphthalene 3_nitroaniline isopropylbenzene 1_methyl_imidazole 3_nitrophenol m_bis_trifluoromethyl__benz 1_methylnaphthalene 3_nitrotoluene ene 1_methyl_pyrrole 3_phenylpropanol m_cresol 1_naphthol 4_acetylpyridine methyl_benzoate 1_naphthylamine 4_bromophenol methyl_p_methoxybenzoate 23_dimethylnaphthalene 4_bromotoluene methyl_p_nitrobenzoate 23_dimethylphenol 4_chloro_3_methylphenol m_xylene 23_dimethylpyridine 4_chloroaniline naphthalene 2 n_butylbenzene bromoethane methyl_p_methoxybenzoate n_hexylbenzene bromomethane methyl_p_nitrobenzoate nitrobenzene dibromomethane methyl_propanoate n_methylaniline halothane methyl_trifluoroacetate n_methyl_n__222_trifluoroet p_dibromobenzene methyl_trimethylacetate hyl__aniline teflurane n_butyl_acetate nn_dimethylaniline n_hexyl_acetate nn_dimethylbenzamide ca_amide n_pentyl_acetate nn_dimethyl_p_methoxybenz benzamide n_pentyl_propanoate amide ethanamide n_propyl_acetate nn_dimethyl_p_methylbenza n_acetylpyrrolidine n_propyl_butyrate mide n_butylacetamide n_propyl_formate nn_dimethyl_p_nitrobenzami n_methylacetamide n_propyl_propanoate de nn_dimethylbenzamide phenyl_formate n_pentylbenzene nn_dimethylformamide triethyl_phosphate n_propylbenzene nn_dimethyl_p_methoxybenz trimethyl_phosphate o_cresol amide o_toluidine nn_dimethyl_p_methylbenza ca_ortho o_xylene mide 111_trifluoro_222_trimethoxy p_cresol nn_dimethyl_p_nitrobenzami ethane p_dibromobenzene de 111_trimethoxyethane phenanthrene 2_chloro_111_trimethoxyetha phenol ca_ester ne phenyl_formate 11_diacetoxyethane 2_methoxy_111_trimethoxyet phenyl_methyl_sulfide 12_diacetoxyethane hane phenyl_trifluoroethyl_ether diethyl_malonate 333_trimethoxypropionitrile p_toluidine diethyl_succinate diethoxymethoxybenzene p_xylene dimethyl_sulfate isoflurane pyrene ethyl_acetate methoxyflurane pyridine ethyl_benzoate trimethoxy_methane pyrrole ethyl_butanoate trimethoxymethylbenzene quinoline ethyl_formate sec_butylbenzene ethyl_hexanoate carbonitrile styrene ethyl_pentanoate 333_trimethoxypropionitrile tert_butylbenzene ethyl_propanoate 3_cyanophenol thiophene isoamyl_acetate 3_cyanopyridine thiophenol isoamyl_formate 4_cyanophenol toluene isobutyl_acetate 4_cyanopyridine trimethoxymethylbenzene isobutyl_formate acetonitrile isobutyl_isobutanoate benzonitrile bromo isopropyl_acetate butanenitrile 12_dibromoethane isopropyl_formate methyl_cyanoacetate 1_bromo_2_chloroethane methyl_acetate pentanenitrile 1_bromo_2_methylpropane methyl_benzoate propanenitrile 1_bromobutane methyl_butanoate 1_bromoheptane methyl_chloroacetate chloro_alkyl 1_bromohexane methyl_cyanoacetate 1112_tetrachloroethane 1_bromooctane methyl_cyclohexanecarboxyl 1122_tetrachloroethane 1_bromopentane ate 112_trichloroethane 1_bromopropane methyl_cyclopropanecarboxyl 11_dichloroethane 2_bromo_2_methylpropane ate 12_dichloroethane 2_bromopropane methyl_formate 12_dichloropropane 4_bromophenol methyl_hexanoate 13_dichloropropane 4_bromotoluene methyl_methanesulfonate 14_dichlorobutane benzyl_bromide methyl_octanoate 1_bromo_2_chloroethane bromobenzene methyl_pentanoate 1_chloro_222_trifluoroethane 3 1_chlorobutane 111_trifluoro_222_trimethoxy 1_chloroheptane ether_alkyl ethane 1_chlorohexane 12_diethoxyethane 111_trifluoropropan_2_ol 1_chloropentane 12_dimethoxyethane 112_trichloro_122_trifluoroet 1_chloropropane 14_dioxane hane 2_chloro_111_trimethoxyetha 25_dimethyltetrahydrofuran 11_dichloroethene ne 2_butoxyethanol 222_trifluoroethanol 2_chloro_2_methylpropane 2_ethoxyethanol benzotrifluoride 2_chlorobutane 2_methoxy_111_trimethoxyet bromotrifluoromethane 2_chloropropane hane chlorodifluoromethane 3_chloroprop_1_ene 2_methoxyethanamine chloroethylene benzyl_chloride 2_methoxyethanol e_12_dichloroethene bis_2_chloroethyl__ether 2_methyltetrahydrofuran hexafluoropropene chloroethane 2_propoxyethanol m_bis_trifluoromethyl__benz chlorofluoromethane bis_2_chloroethyl__ether ene chloromethane diethyl_ether methyl_trifluoroacetate dichloromethane diisopropyl_ether n_methyl_n__222_trifluoroet halothane dimethyl_ether hyl__aniline isoflurane di_n_butyl_ether tetrachloroethene methoxyflurane di_n_propyl_ether tetrachloromethane methyl_chloroacetate methyl_ethyl_ether tetrafluoromethane pentachloroethane methyl_isopropyl_ether tribromomethane methyl_propyl_ether trichloroethene chloro_aryl methyl_t_butyl_ether trichloromethane 1234_tetrachlorobenzene morpholine z_12_dichloroethene 1235_tetrachlorobenzene n_methylmorpholine 123_trichlorobenzene tetrahydrofuran heterocyclic 1245_tetrachlorobenzene tetrahydropyran 14_dimethyl_piperazine 124_trichlorobenzene 14_dioxane 12_dichlorobenzene ether_aryl 1_methyl_imidazole 135_trichlorobenzene 2_methoxyaniline 1_methyl_pyrrole 13_dichlorobenzene 2_methoxyphenol 23_dimethylpyridine 14_dichlorobenzene 3_methoxyaniline 24_dimethylpyridine 2_chloroaniline 3_methoxyphenol 25_dimethylpyridine 2_chlorophenol 4_methoxyacetophenone 25_dimethyltetrahydrofuran 2_chloropyridine 4_methoxyaniline 26_dimethylpyridine 2_chlorotoluene anisole 2_chloropyridine 3_chloroaniline ethyl_phenyl_ether 2_ethylpyrazine 3_chlorophenol
Recommended publications
  • (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al

    (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al

    USOO6264,917B1 (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness et al. (45) Date of Patent: Jul. 24, 2001 (54) TARGETED ULTRASOUND CONTRAST 5,733,572 3/1998 Unger et al.. AGENTS 5,780,010 7/1998 Lanza et al. 5,846,517 12/1998 Unger .................................. 424/9.52 (75) Inventors: Jo Klaveness; Pál Rongved; Dagfinn 5,849,727 12/1998 Porter et al. ......................... 514/156 Lovhaug, all of Oslo (NO) 5,910,300 6/1999 Tournier et al. .................... 424/9.34 FOREIGN PATENT DOCUMENTS (73) Assignee: Nycomed Imaging AS, Oslo (NO) 2 145 SOS 4/1994 (CA). (*) Notice: Subject to any disclaimer, the term of this 19 626 530 1/1998 (DE). patent is extended or adjusted under 35 O 727 225 8/1996 (EP). U.S.C. 154(b) by 0 days. WO91/15244 10/1991 (WO). WO 93/20802 10/1993 (WO). WO 94/07539 4/1994 (WO). (21) Appl. No.: 08/958,993 WO 94/28873 12/1994 (WO). WO 94/28874 12/1994 (WO). (22) Filed: Oct. 28, 1997 WO95/03356 2/1995 (WO). WO95/03357 2/1995 (WO). Related U.S. Application Data WO95/07072 3/1995 (WO). (60) Provisional application No. 60/049.264, filed on Jun. 7, WO95/15118 6/1995 (WO). 1997, provisional application No. 60/049,265, filed on Jun. WO 96/39149 12/1996 (WO). 7, 1997, and provisional application No. 60/049.268, filed WO 96/40277 12/1996 (WO). on Jun. 7, 1997. WO 96/40285 12/1996 (WO). (30) Foreign Application Priority Data WO 96/41647 12/1996 (WO).
  • 160 'Ideal' Gases: Anaesthetics in the Heart of the Twentieth Century Ian

    160 'Ideal' Gases: Anaesthetics in the Heart of the Twentieth Century Ian

    International Workshop on the History of Chemistry 2015 Tokyo ‘Ideal’ Gases: Anaesthetics in the Heart of the Twentieth Century Ian D. Rae University of Melbourne, Australia 1. Introduction By 1920 only three gaseous anaesthetics were widely used – nitrous oxide, diethyl ether (ether) and chloroform. The toxicity of chloroform was acknowledged, nitrous oxide did not induce deep anaesthesia, and ether was extremely inflammable, so in the 1920s there were good reasons to search for new anaesthetics. While my concern is with gaseous anaesthetics, I recognise that there were parallel developments in two related fields, that of topical or local anaesthetics, typified by the natural product cocaine and a host of synthetic substances, and injectable anaesthetics starting with opiates, then barbiturates and leading to modern materials such as propofol (2,6-diisopropylphenol). 2. Theories of anaesthetic action Hans Meyer1 noted that the anaesthetic substances were soluble in both fatty and aqueous media, proposed a general theory of anaesthesia based on the partition or distribution coefficient as a critical determinant. Meyer enunciated the following three principles that underpinned his theory: all chemically inert substances that are soluble in fats and fatty materials will produce narcosis; the line of action is in the nerve cells; the comparative strengths of substances depend on their solubility in fatty material and in water, that is, on the distribution coefficient. Charles Overton arrived at the same idea independently. Some years after completing his PhD research on cell permeability studies, Overton first presented his theory of narcosis in a lecture to the Society for Natural History in Zurich in October 1898, in a paper published the following year2 and in his book3 which included a full exposition.
  • Customs Tariff - Schedule

    Customs Tariff - Schedule

    CUSTOMS TARIFF - SCHEDULE 99 - i Chapter 99 SPECIAL CLASSIFICATION PROVISIONS - COMMERCIAL Notes. 1. The provisions of this Chapter are not subject to the rule of specificity in General Interpretative Rule 3 (a). 2. Goods which may be classified under the provisions of Chapter 99, if also eligible for classification under the provisions of Chapter 98, shall be classified in Chapter 98. 3. Goods may be classified under a tariff item in this Chapter and be entitled to the Most-Favoured-Nation Tariff or a preferential tariff rate of customs duty under this Chapter that applies to those goods according to the tariff treatment applicable to their country of origin only after classification under a tariff item in Chapters 1 to 97 has been determined and the conditions of any Chapter 99 provision and any applicable regulations or orders in relation thereto have been met. 4. The words and expressions used in this Chapter have the same meaning as in Chapters 1 to 97. Issued January 1, 2019 99 - 1 CUSTOMS TARIFF - SCHEDULE Tariff Unit of MFN Applicable SS Description of Goods Item Meas. Tariff Preferential Tariffs 9901.00.00 Articles and materials for use in the manufacture or repair of the Free CCCT, LDCT, GPT, UST, following to be employed in commercial fishing or the commercial MT, MUST, CIAT, CT, harvesting of marine plants: CRT, IT, NT, SLT, PT, COLT, JT, PAT, HNT, Artificial bait; KRT, CEUT, UAT, CPTPT: Free Carapace measures; Cordage, fishing lines (including marlines), rope and twine, of a circumference not exceeding 38 mm; Devices for keeping nets open; Fish hooks; Fishing nets and netting; Jiggers; Line floats; Lobster traps; Lures; Marker buoys of any material excluding wood; Net floats; Scallop drag nets; Spat collectors and collector holders; Swivels.
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
  • Stembook 2018.Pdf

    Stembook 2018.Pdf

    The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances FORMER DOCUMENT NUMBER: WHO/PHARM S/NOM 15 WHO/EMP/RHT/TSN/2018.1 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances. Geneva: World Health Organization; 2018 (WHO/EMP/RHT/TSN/2018.1). Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data.
  • I (Acts Whose Publication Is Obligatory) COMMISSION

    I (Acts Whose Publication Is Obligatory) COMMISSION

    13.4.2002 EN Official Journal of the European Communities L 97/1 I (Acts whose publication is obligatory) COMMISSION REGULATION (EC) No 578/2002 of 20 March 2002 amending Annex I to Council Regulation (EEC) No 2658/87 on the tariff and statistical nomenclature and on the Common Customs Tariff THE COMMISSION OF THE EUROPEAN COMMUNITIES, Nomenclature in order to take into account the new scope of that heading. Having regard to the Treaty establishing the European Commu- nity, (4) Since more than 100 substances of Annex 3 to the Com- bined Nomenclature, currently classified elsewhere than within heading 2937, are transferred to heading 2937, it is appropriate to replace the said Annex with a new Annex. Having regard to Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Com- mon Customs Tariff (1), as last amended by Regulation (EC) No 2433/2001 (2), and in particular Article 9 thereof, (5) Annex I to Council regulation (EEC) No 2658/87 should therefore be amended accordingly. Whereas: (6) This measure does not involve any adjustment of duty rates. Furthermore, it does not involve either the deletion of sub- stances or addition of new substances to Annex 3 to the (1) Regulation (EEC) No 2658/87 established a goods nomen- Combined Nomenclature. clature, hereinafter called the ‘Combined Nomenclature’, to meet, at one and the same time, the requirements of the Common Customs Tariff, the external trade statistics of the Community and other Community policies concerning the (7) The measures provided for in this Regulation are in accor- importation or exportation of goods.
  • (12) United States Patent (Lo) Patent No.: �US 8,480,637 B2

    (12) United States Patent (Lo) Patent No.: US 8,480,637 B2

    111111111111111111111111111111111111111111111111111111111111111111111111 (12) United States Patent (lo) Patent No.: US 8,480,637 B2 Ferrari et al. (45) Date of Patent : Jul. 9, 2013 (54) NANOCHANNELED DEVICE AND RELATED USPC .................. 604/264; 907/700, 902, 904, 906 METHODS See application file for complete search history. (75) Inventors: Mauro Ferrari, Houston, TX (US); (56) References Cited Xuewu Liu, Sugar Land, TX (US); Alessandro Grattoni, Houston, TX U.S. PATENT DOCUMENTS (US); Daniel Fine, Austin, TX (US); 5,651,900 A 7/1997 Keller et al . .................... 216/56 Randy Goodall, Austin, TX (US); 5,728,396 A 3/1998 Peery et al . ................... 424/422 Sharath Hosali, Austin, TX (US); Ryan 5,770,076 A 6/1998 Chu et al ....................... 210/490 5,798,042 A 8/1998 Chu et al ....................... 210/490 Medema, Pflugerville, TX (US); Lee 5,893,974 A 4/1999 Keller et al . .................. 510/483 Hudson, Elgin, TX (US) 5,938,923 A 8/1999 Tu et al . ........................ 210/490 5,948,255 A * 9/1999 Keller et al . ............. 210/321.84 (73) Assignees: The Board of Regents of the University 5,985,164 A 11/1999 Chu et al ......................... 516/41 of Texas System, Austin, TX (US); The 5,985,328 A 11/1999 Chu et al ....................... 424/489 Ohio State University Research (Continued) Foundation, Columbus, OH (US) FOREIGN PATENT DOCUMENTS (*) Notice: Subject to any disclaimer, the term of this WO WO 2004/036623 4/2004 WO WO 2006/113860 10/2006 patent is extended or adjusted under 35 WO WO 2009/149362 12/2009 U.S.C. 154(b) by 612 days.
  • Marrakesh Agreement Establishing the World Trade Organization

    Marrakesh Agreement Establishing the World Trade Organization

    No. 31874 Multilateral Marrakesh Agreement establishing the World Trade Organ ization (with final act, annexes and protocol). Concluded at Marrakesh on 15 April 1994 Authentic texts: English, French and Spanish. Registered by the Director-General of the World Trade Organization, acting on behalf of the Parties, on 1 June 1995. Multilat ral Accord de Marrakech instituant l©Organisation mondiale du commerce (avec acte final, annexes et protocole). Conclu Marrakech le 15 avril 1994 Textes authentiques : anglais, français et espagnol. Enregistré par le Directeur général de l'Organisation mondiale du com merce, agissant au nom des Parties, le 1er juin 1995. Vol. 1867, 1-31874 4_________United Nations — Treaty Series • Nations Unies — Recueil des Traités 1995 Table of contents Table des matières Indice [Volume 1867] FINAL ACT EMBODYING THE RESULTS OF THE URUGUAY ROUND OF MULTILATERAL TRADE NEGOTIATIONS ACTE FINAL REPRENANT LES RESULTATS DES NEGOCIATIONS COMMERCIALES MULTILATERALES DU CYCLE D©URUGUAY ACTA FINAL EN QUE SE INCORPOR N LOS RESULTADOS DE LA RONDA URUGUAY DE NEGOCIACIONES COMERCIALES MULTILATERALES SIGNATURES - SIGNATURES - FIRMAS MINISTERIAL DECISIONS, DECLARATIONS AND UNDERSTANDING DECISIONS, DECLARATIONS ET MEMORANDUM D©ACCORD MINISTERIELS DECISIONES, DECLARACIONES Y ENTEND MIENTO MINISTERIALES MARRAKESH AGREEMENT ESTABLISHING THE WORLD TRADE ORGANIZATION ACCORD DE MARRAKECH INSTITUANT L©ORGANISATION MONDIALE DU COMMERCE ACUERDO DE MARRAKECH POR EL QUE SE ESTABLECE LA ORGANIZACI N MUND1AL DEL COMERCIO ANNEX 1 ANNEXE 1 ANEXO 1 ANNEX
  • Extending the Possibilities of Biopartitioning Chromatography for Improved Prediction of in Vivo Drug Absorption

    Extending the Possibilities of Biopartitioning Chromatography for Improved Prediction of in Vivo Drug Absorption

    Extending the possibilities of biopartitioning chromatography for improved prediction of in vivo drug absorption Mike De Vrieze Promotor: Prof. Dr. F. Lynen Co-promotor: Prof. Dr. P. Sandra 2015 Thesis submitted to obtain the degree of Doctor in Sciences, Chemistry Extending the possibilities of biopartitioning chromatography for improved prediction of in vivo drug absorption Mike De Vrieze Promotor: Prof. Dr. F. Lynen Co-promotor: Prof. Dr. P. Sandra 2015 Thesis submitted to obtain the degree of Doctor in Sciences, Chemistry Table of contents Table of contents Chapter I. General introduction and aims of the work ..................................... 1 I.1 References ................................................................................................................. 5 Chapter II. Description of the structure, function and delivery across the Blood-Brain Barrier ............................................................................................... 7 II.1 Structure and function of the blood-brain barrier ............................................... 7 II.1.1 Transport across the blood-brain barrier ....................................................................... 12 II.1.2 Functions of the blood-brain barrier .............................................................................. 15 II.1.3 Controlling the permeability of the blood-brain barrier ................................................ 15 II.2 Principles of drug delivery across the blood-brain barrier ................................ 17 II.2.1
  • Location of the Mesopontine Neurons Responsible for Maintanance of Anesthetic Loss of Consciousness

    Location of the Mesopontine Neurons Responsible for Maintanance of Anesthetic Loss of Consciousness

    This Accepted Manuscript has not been copyedited and formatted. The final version may differ from this version. Research Articles: Systems/Circuits Location of the mesopontine neurons responsible for maintanance of anesthetic loss of consciousness Anne Minert1, Shai-Lee Yatziv1 and Marshall Devor1 1Department of Cell and Developmental Biology, Institute of Life Sciences, and Center for Research on Pain, The Hebrew University of Jerusalem, Jerusalem 91904, Israel DOI: 10.1523/JNEUROSCI.0544-17.2017 Received: 26 February 2017 Revised: 6 August 2017 Accepted: 9 August 2017 Published: 16 August 2017 Author contributions: A.M. and M.D. designed research; A.M., S.-l.Y., and M.D. performed research; A.M., S.- l.Y., and M.D. analyzed data; A.M. and M.D. wrote the paper. Conflict of Interest: The authors declare no competing financial interests. Lead Contact for this paper. Correspondence should be sent to: Prof. M. Devor, Department of Cell and Developmental Biology, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel Tel.: +972 2 658-5085 Cite as: J. Neurosci ; 10.1523/JNEUROSCI.0544-17.2017 Alerts: Sign up at www.jneurosci.org/cgi/alerts to receive customized email alerts when the fully formatted version of this article is published. Accepted manuscripts are peer-reviewed but have not been through the copyediting, formatting, or proofreading process. Copyright © 2017 the authors August 5, 2017 Journal of Neuroscience JN-RM-0544-17R2 1 2 3 4 Location of the mesopontine neurons responsible for maintanance of anesthetic loss of 5 consciousness 6 7 ANNE MINERT1, SHAI-LEE YATZIV 1 and MARSHALL DEVOR1* 8 1 Department of Cell and Developmental Biology 9 Institute of Life Sciences 10 and Center for Research on Pain 11 The Hebrew University of Jerusalem 12 Jerusalem 91904, Israel 13 14 15 Running title: Transient loss of consciousness 16 17 * Lead Contact for this paper.

  • Experimental Evaluation and Modeling of Sorption Behavior of Neutral Organic Chemicals in Storage Lipids

    Experimental Evaluation and Modeling of Sorption Behavior of Neutral Organic Chemicals in Storage Lipids Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften (Dr. rer. nat.) der Naturwissenschaftlichen Fakultät II Chemie, Physik und Mathematik der Martin–Luther–Universität Halle–Wittenberg vorgelegt von Frau Anett Krause geb. am 28.07.1983 in Schkeuditz Gutachter: Prof. Dr. Kai-Uwe Goss Prof. Dr. Beate Escher Arbeit eingericht am: 22. Dezember 2015 Tag der öffentlichen Verteidigung: 20. Juni 2016 Contents Abstract 1 Preface 5 1 Experimental evaluation and modeling of sorption behavior of neutral organic chemicals in storage lipids 6 1.1 Introduction................................... 6 1.2 Objectiveofthisstudy ... .. ... ... .. ... ... .. ... ... 8 1.3 Materials .................................... 8 1.4 Experimentalwork ............................... 9 1.5 Experimental determination of pp-LFER system parameters ........ 10 1.5.1 Similarity of different storage lipids . ..... 10 1.5.2 Calibration of an universal pp-LFER for storage lipids ....... 12 1.5.3 Octanol as a surrogate for storage lipid . 13 1.6 Temperaturedependence. 14 1.7 Validation of COSMOtherm, ABSOLV, KOWWIN and SPARC . 16 1.7.1 Predictionmodels............................ 16 1.7.2 Experimental data for model evaluation . 17 1.7.3 Validationresults ............................ 17 1.8 Conclusions ................................... 23 1.9 Physicochemical properties and experimental results for the chemicals in section1.5and1.6 ............................... 24 2 Abstracts of the original publications 38 Bibliography 42 Angaben zur Person 48 Erklärung 50 List of Figures 1.1 Partition coefficients for human milk (n = 73) and cow raw milk (n = 54) compared to processed cow milk (experimental data, 37 ◦C)......... 10 1.2 Experimental storage lipid/water partition coefficients for all compounds and all lipids versus storage lipid/water partition coefficient calculated with eq 1.4; 517 datapoints ............................

  • C1-C4 Halogenated HC Info 16FEB2018.Xlsx

    C1-C4 Halogenated Hydrocarbons/Halocarbons Not Otherwise Listed (C1-C4 NOL) Feb 28, 2018 Administrative Council Mtg - Printed 2/16/20184:11 PM Reported Uses (SOURCES:HAZMAP, NJDHSS, Wikipedia, TSCA CDR, mfr literature) TURA TSCA CDR Chemical CAS/Chemica chemical name chemical fire 2015 Chemical Name Pesti- blowing feedstock / supressant / propell- Inventory? TRI? List l Number (synonyms) formula Solvent refriger-ant etchant Other Tier II cide agent intermed-iate flame ant status* retardant insulation for refrigerators, freezers, commercial refrigeration equipment, refrigerated containers and LNG ships; spray foam insulation; insulated metal panels; slabstock and molded flexible foam; refrigerant for chillers; and solvents for metal cleaning and electronics, and circuit flush. https://www.honeywell-blowingagents.com/?document=solstice-lba-technical- HFO-1233zd (E) brochure&download=1 Hydro-fluoro-olefin C H ClF YYY yhttps://www.honeywell-refrigerants.com/americas/product/solstice-zd/ (HFO) 3 2 3 CDR 2016 Honeywell: 100% as propellants and blowing agents for plastics product mfg; R-1233zd CDR Honeywell Solstice® ZD refrigerant, Solstice® 1233zdE, Solstice Blowing Agent; Arkema (current Forane® 1233zd blowing agent for spray PU foam, appliance insulation, etc. and solvent (may Honeywell not be available in US) product) C1-C4 Cat 102687-65-0 1-Chloro-3,3,3-trifluoropropene Y 106‐95‐6 Allyl bromide 2-Propenyl bromide C3H5Br Y y Manufacture of synthetic perfumes, other allyl compounds; Insecticidal fumigant; 1-Propene, 3-bromo- Chemical intermediate in organic synthesis, for resins (copolymer with sulfur dioxide) and fragrances; As a fumigant (if quite volatile) or as a contact poison; C1-C4 Cat Used in the manufacture of plastics and dyestuff.